C9 is the terminal Component of the complement cascade, which has also been found to be elevated in serum of gastric [38], lung [39], colorectal [40, 41] and esophageal cancers [17, 18] through proteomics or glycoproteomic approaches. The gene discussed is C9; the disease is esophageal cancer.